SUD 0.00% 4.2¢ suda pharmaceuticals ltd

AYTU, page-4

  1. 5,698 Posts.
    lightbulb Created with Sketch. 82
    In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Aytu BioScience Inc (AYTU), with a price target of $10. The company’s shares opened today at $2.06.

    $10 would give them a MC of around $A200m.

    Wonder what Carl thinks of Suda.
 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.